
Applaud Medical Inc Profile last edited on: 8/29/22
CAGE: 78L61
UEI: N5XMYSLHQAP7
Business Identifier: Breakthrough technology to improve treatment of urinary stone disease. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: San Francisco
Congr. District: 12
County: San Francisco
Public Profile
Applaud Medical is structured around development of new methods for treatment of Urinary (kidney) Stones - a medical problem that factors (in the United States alone) to <2,000,000 emergency room visits annually. Currently, treatment of large stones requires anesthesia in an operating room with a less invasive surgical intervention addressing the problem effectively - rendering them stone-free - in only some 50% of patients. The firm's Acoustic Enhancer is designed to accelerate and amplify the fragmentation process - providing faster procedures and better patient outcomes: an innovative kidney stone treatment that - for the first time - could allow urologists effectively to treat 5-15 millimeter stones with a simple outpatient procedure. In January 2022 it was announced that Applaud Medical had received the FDA Breakthrough Device Designation for the companyâs acoustic enhancer for use in conjunction with ureteroscopy wiith Laser Lithotripsy (URS-LL) for the fragmentation of calcium-based kidney stones Jan 31, 2022 |
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
15-19Revenue Range
1.5M-2MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2021 | 1 | NIH | $256,539 | |
Project Title: Engineered microbubbles to augment laser lithotripsy of urinary stones |
Key People / Management
Thomas Kenny -- CEO and Founder
William Behnke-Parks -- Director of Advanced Technology
Daniel Lase -- co_Founder
Alice Luong -- Director of Technical Operations and Head of Chemistry Director
Matt Mellema -- Vice President for Product Development
Claire Mills -- Co Founder, Ultrasound Imaging and Clinical Affairs Specialist
Yuri A Pishchalnikov
Marshall Stoller -- Co-Founder
Tessa Yamut -- Executive Vice President of Regulatory, Clinical and Quality Affairs
William Behnke-Parks -- Director of Advanced Technology
Daniel Lase -- co_Founder
Alice Luong -- Director of Technical Operations and Head of Chemistry Director
Matt Mellema -- Vice President for Product Development
Claire Mills -- Co Founder, Ultrasound Imaging and Clinical Affairs Specialist
Yuri A Pishchalnikov
Marshall Stoller -- Co-Founder
Tessa Yamut -- Executive Vice President of Regulatory, Clinical and Quality Affairs
Company News
There are no news available.